Henry Ford Health has treated the first Michigan patient outside clinical trials with Roctavian, the newly approved gene ...

With the exception of infectious diseases, examination of the environmental causes of illness has been piecemeal. Gary Miller, a toxicologist at Columbia University who also addressed the meeting, ...

Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops and behaves, ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

The patient, who is in his 30s, got the one-time intravenous infusion at the Infusion and Chemotherapy Treatment Center at ...

It took a while for the science to basically catch up to that suspicion.” In these types of “recessive” conditions, the ...

If an athlete can raise their population of red blood cells by a few percentage points, that represents a huge competitive ...

A biotechnology firm hatched by two prominent researchers publicly debuted on Friday, aiming to use a new regulatory framework to quickly develop many gene editing treatments for rare diseases. Called ...

Introduction: Lymphocytic variant hypereosinophilic syndrome (L-HES) is a rare subtype of hypereosinophilic syndrome driven by aberrant T-cell clones that promote eosinophilia through interleukin-5 ...

A major evolutionary theory says most genetic changes don’t really matter, but new evidence suggests that’s not true. Researchers found that helpful mutations happen surprisingly often. The twist is ...

Before Todd Leach lost his father to a rare, aggressive form of stomach cancer, his dad gave him one last gift: a genetic test. It was then that Leach, of Cabot, Arkansas, learned his father carried a ...